PYNKF (PYNKF) Stock Price & Analysis
PYNKF (PYNKF) rose 0.00% to USD 0.22 as of July 25, 2026 at 11:18 UTC, according to Nexqual real-time market data.
PYNKF last closed at USD 0.22; the session ranged USD 0.22–0.23 on volume of 8,500 shares. Market capitalization is $33.14M, with a 52-week range of USD 0.11–0.53 (OQX). Source: Nexqual, July 25, 2026 at 11:18 UTC.
Key Statistics (as of July 25, 2026 at 11:18 UTC)
| Price | USD 0.22 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.22 |
| Open | USD 0.23 |
| Day Range | USD 0.22 – 0.23 |
| 52-Week Range | USD 0.11 – 0.53 |
| Volume | 8,500 shares |
| Market Cap | $33.14M |
| Exchange | OQX |
Technical Analysis (PYNKF)
Nexqual's technical model rates PYNKF "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 11:18 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.31 (neutral) |
| vs SMA50 | Above (USD 0.22) |
| MACD | 0 (positive) |
Analyst Ratings (PYNKF)
Wall Street analysts rate PYNKF "None", per Nexqual as of July 25, 2026 at 11:18 UTC.
| Consensus Rating | None |
|---|
Earnings (PYNKF)
| Next Earnings Date | 2026-08-25 |
|---|---|
| Revenue Estimate | $885,000 |
Source: Nexqual, July 25, 2026 at 11:18 UTC.
Financials & Fundamentals (PYNKF)
| Total Revenue | $2.14M |
|---|---|
| Revenue Growth (YoY) | -30.10% |
| Gross Margin | +83.74% |
| Operating Margin | -774.92% |
| Profit Margin | +0.00% |
| ROE | -284.87% |
| Debt / Equity | 6.38 |
| Current Ratio | 0.55 |
| Total Cash | $421,496 |
| Total Debt | $104,015 |
| Free Cash Flow | $-3.92M |
Source: Nexqual, July 25, 2026 at 11:18 UTC.
Financial Health Score (PYNKF)
Nexqual rates PYNKF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 11:18 UTC.
| Growth | Strong — Revenue +166% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $421K cash, no debt |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -285%, ROA -108.9% |
Ownership (PYNKF)
| Insider Ownership | +18.71% |
|---|---|
| Institutional Ownership | +19.01% |
| Shares Outstanding | 150.65M |
| Float | 82.24M |
Source: Nexqual, July 25, 2026 at 11:18 UTC.
Leadership (PYNKF)
PYNKF is led by Adrian Mendes, CEO & Director, per Nexqual as of July 25, 2026 at 11:18 UTC.
| CEO & Director | Adrian Mendes |
|---|---|
| Chief Financial Officer | Sara Brien |
| Vice President of Sales | Abbey Goodman (age 42) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ASAPF | Aurora Spine Corp | USD 0.16 | ▼ 2.19% |
| ADCOF | Adcore Inc. | USD 0.11 | ▲ 5.6% |
| AVCNF | Avicanna Inc. | USD 0.1 | ▼ 0.99% |
| BRSF | BRAIN SCIENTIFIC INC | USD 0 | ▲ 0% |
| EGTYF | Eguana Technologies Inc | USD 0 | ▼ 95.95% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 11:18 UTC. This page is informational and not investment advice.